engineered interferon ORB-011
Term · Oncology and biomedicine · MLC-T-ONC-013345
An attenuated, cis-targeted interferon (IFN), with potential immunostimulating and antineoplastic activities. Upon administration, engineered IFN ORB-011 specifically targets, binds to and activates type 1 conventional dendritic cell (cDC1). As these are specific immune cells that specialize in presenting tumor antigens to, and activating, tumor cytotoxic CD8 T cells, ORB-011 may be able to stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune response. ORB-011 is engineered in such a way as to minimize off-target IFN-based binding and thereby avoiding systemic toxicity.
| Identifier | MLC-T-ONC-013345 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cis-targeted interferon ORB-011; engineered cytokine ORB-011; engineered IFN ORB-011 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013345",
"term": "engineered interferon ORB-011",
"field": "Oncology and biomedicine",
"definition": "An attenuated, cis-targeted interferon (IFN), with potential immunostimulating and antineoplastic activities. Upon administration, engineered IFN ORB-011 specifically targets, binds to and activates type 1 conventional dendritic cell (cDC1). As these are specific immune cells that specialize in presenting tumor antigens to, and activating, tumor cytotoxic CD8 T cells, ORB-011 may be able to stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated anti-tumor immune response. ORB-011 is engineered in such a way as to minimize off-target IFN-based binding and thereby avoiding systemic toxicity.",
"synonyms": [
"cis-targeted interferon ORB-011",
"engineered cytokine ORB-011",
"engineered IFN ORB-011"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/engineered-interferon-orb-011/"
}
Record 6,681 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.